Moreover, upregulated PLK1 was associated with a higher pathologic T stage, N stage, and Gleason scores, and high expression of PLK1 was indicative of a poor prognosis in prostate cancer (Supplementary Figure S5B‒F). Here, PLK1 is linked to prostate carcinoma.